Hong Kong S.a.r.
Deep Longevity, founded in 2020, is a biotechnology and health care startup based in Hong Kong S.a.r. The company's slogan, "Using Science of Longevity to Improve Healthspan & Lifespan", encapsulates its core focus. Deep Longevity is at the forefront of developing explainable artificial intelligence systems to track the rate of aging at various levels, from molecular to psychological. Its goal is to enable physicians to make informed decisions regarding interventions that may slow down or reverse the aging process.
The company has introduced a Longevity as a Service (LaaS)© solution, integrating multiple deep biomarkers of aging called "deep aging clocks" to provide a universal multifactorial measure of human biological age. This innovative approach has attracted significant attention and support from prominent venture capitalists specializing in biotechnology, longevity, and artificial intelligence. In July 2020, Deep Longevity secured a Series A investment from investors including BOLD Capital Partners, Emerging Technology Partners, Formic Ventures, Longevity Vision Fund, LongeVC, and Human Longevity and Performance Impact Venture Fund, indicating strong confidence in the company's potential.
Given the increasing interest and investment in longevity and biotechnology, Deep Longevity's approach holds promise for revolutionizing the field of longevity medicine and aging intervention. With the backing of notable investors and a robust technological foundation, the company is poised to drive significant advancements in extending healthspan and lifespan, potentially reshaping the future of healthcare.
